[PDF][PDF] Progress and prospects of elastography techniques in the evaluation of fibrosis in chronic liver disease
Y Wang, X Yang, S Wang - Archives of …, 2024 - archivesofmedicalscience.com
The precise assessment of liver fibrosis degree is imperative for monitoring and managing
chronic liver diseases. Traditionally, liver biopsy and quantitative blood biomarkers have …
chronic liver diseases. Traditionally, liver biopsy and quantitative blood biomarkers have …
[HTML][HTML] 非酒精性脂肪肝病和血管疾病: 临床证据与机制回顾
屈飏， 张百慧 - Advances in Clinical Medicine, 2023 - hanspub.org
非酒精性脂肪性肝病(nonalcoholic fatty liver disease, NAFLD) 是全球肝病负担日益加重的重要
原因. 全世界约有25% 的成年人可能受到NAFLD 的影响. 由于NAFLD 通常与肥胖, 2 …
原因. 全世界约有25% 的成年人可能受到NAFLD 的影响. 由于NAFLD 通常与肥胖, 2 …
[HTML][HTML] Advancing towards accurate phenotyping based on metabolic and fibrosis risk in metabolic-dysfunction associated steatotic liver disease: one step closer to …
S Muñoz-Martínez, A Jiménez-Masip… - … Surgery and Nutrition, 2024 - ncbi.nlm.nih.gov
The study by Ajmera et al.(10) greatly contributes to filling several important gaps, ie,
prospective data, a cohort of patients enrolled in primary care and endocrinology clinics …
prospective data, a cohort of patients enrolled in primary care and endocrinology clinics …
[HTML][HTML] The importance of age for liver-related mortality in patients with metabolic-dysfunction associated steatotic liver disease
ES Bjornsson - Hepatobiliary Surgery and Nutrition, 2024 - ncbi.nlm.nih.gov
© HepatoBiliary Surgery and Nutrition. All rights reserved. HepatoBiliary Surg Nutr 2024; 13
(1): 124-127| https://dx. doi. org/10.21037/hbsn-23-557 patients with NAFLD is of major …
(1): 124-127| https://dx. doi. org/10.21037/hbsn-23-557 patients with NAFLD is of major …
[HTML][HTML] Fibroscan-AST (FAST) score and other non-invasive tests for the diagnosis of fibrotic non-alcoholic steatohepatitis
WL Chan, CVC Kumar, WK Chan - Hepatobiliary Surgery and …, 2023 - ncbi.nlm.nih.gov
NASH, non-alcoholic steatohepatitis; AUROC, areas under the receiver operating
characteristic curves; CI, confidence interval; PPV, positive predictive value; NPV, negative …
characteristic curves; CI, confidence interval; PPV, positive predictive value; NPV, negative …
Exploring autoantibodies as predictors of severe fibrosis or cirrhosis in metabolic dysfunction associated with steatotic liver disease
M Ragheb, M Grubert Van Iderstine… - Canadian Liver …, 2024 - canlivj.utpjournals.press
Background: Metabolic dysfunction associated steatotic liver disease (MASLD) and
metabolic dysfunction associated steatohepatitis (MASH) are rapidly growing public health …
metabolic dysfunction associated steatohepatitis (MASH) are rapidly growing public health …
[PDF][PDF] Paediatric steatotic liver disease has unique characteristics
J Mann - 2024 - pure-oai.bham.ac.uk
Nonalcoholic fatty liver disease (NAFLD) has been a commonly used term and diagnosis in
paediatric hepatology, gastroenterology, and endocrinology clinics for over 30 years. A …
paediatric hepatology, gastroenterology, and endocrinology clinics for over 30 years. A …
[PDF][PDF] Dr. rer. nat. Ines Witte
HH Bleß - monitor-versorgungsforschung.de
Zusammenfassung Die Metabolische Dysfunktion-assoziierte Steatotische Lebererkrankung
(MASLD), vormals bekannt als nichtalkoholische Fettlebererkrankung (NAFLD), ist eine …
(MASLD), vormals bekannt als nichtalkoholische Fettlebererkrankung (NAFLD), ist eine …
[PDF][PDF] Amendment „Neue Nomenklatur zur MASLD (Metabolic Dysfunction Associated Steatotic Liver Disease; metabolische Dysfunktion assoziierte steatotische …
E Roeb, A Canbay, H Bantel, J Bojunga, J de Laffolie… - register.awmf.org
Amendment „Neue Nomenklatur zur MASLD (Metabolic Dysfunction Associated Steatotic
Liver Disease; metabolische Dysfunktion asso Page 1 Amendment „Neue Nomenklatur zur …
Liver Disease; metabolische Dysfunktion asso Page 1 Amendment „Neue Nomenklatur zur …
[HTML][HTML] The Utility of a Novel Stacked Microvascular Imaging for Enhanced Detection of Fibrosis in Chronic Liver Diseases
D Miura, H Suenaga, K Ichihara - Ultrasound in Medicine & Biology, 2024 - Elsevier
Objective Ultrasonographic imaging plays a primary role to detect fibrotic changes in
patients with chronic liver disease (CLD). To enhance detectability of fibrosis in its early …
patients with chronic liver disease (CLD). To enhance detectability of fibrosis in its early …